GRI vs IDXX · P/E 0.1, $3.5M cap vs P/E 40, rev $2.36B
GRI Bio Inc. (GRI) versus IDEXX Laboratories Inc (IDXX) — a side-by-side from cached financials, not a winner call.
GRI Bio Inc. (GRI) is a biotechnology company listed on US.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
GRI does not have a complete income-statement cache yet.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
GRI currently screens at market cap $3.5M and trailing P/E 0.1. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Not investment advice. Open the GRI and IDXX stock pages for the full models.
Not investment advice.